⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplementary Fig. 4 from Disruption of the MYC Super-Enhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia

William M. Yashar Brittany M. Curtiss Daniel J. Coleman Jake VanCampen Garth Kong Jommel Macaraeg Joseph Estabrook Emek Demir Nicola Long Daniel Bottomly Shannon K. McWeeney Jeffrey Tyner Brian Druker Julia E. Maxson Theodore P. Braun

View at Publisher

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Dual FLT3/LSD1 inhibition suppresses MYC expression and activity.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yashar et al. (2024) studied this question.

synapsesocial.com/papers/68e586c1b6db643587523a03 https://doi.org/10.1158/1541-7786.27034633

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Fig. 4 from Disruption of the MYC Super-Enhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia2024
2Supplementary Fig. 5 from Disruption of the MYC Super-Enhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia2024
3Supplementary Fig. 5 from Disruption of the MYC Super-Enhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia2024
4Supplementary Fig. 6 from Disruption of the MYC Super-Enhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia2024
5Supplementary Fig. 8 from Disruption of the MYC Super-Enhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia2024
6Supplementary Fig. 12 from Disruption of the MYC Super-Enhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia2024
7Supplementary Fig. 12 from Disruption of the MYC Super-Enhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia2024
8Supplementary Fig. 3 from Disruption of the MYC Super-Enhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia2024